BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11162118)

  • 1. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
    Jäger M; Gehrig P; Plückthun A
    J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.
    Jäger M; Plückthun A
    Protein Sci; 2000 Mar; 9(3):552-63. PubMed ID: 10752617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
    Ramm K; Gehrig P; Plückthun A
    J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M; Plückthun A
    J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folding nuclei of the scFv fragment of an antibody.
    Freund C; Honegger A; Hunziker P; Holak TA; Plückthun A
    Biochemistry; 1996 Jun; 35(25):8457-64. PubMed ID: 8679604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure.
    Lilie H; Rudolph R; Buchner J
    J Mol Biol; 1995 Apr; 248(1):190-201. PubMed ID: 7731044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a hydrophobically collapsed intermediate on the conformational folding pathway of ribonuclease A probed by hydrogen-deuterium exchange.
    Houry WA; Scheraga HA
    Biochemistry; 1996 Sep; 35(36):11734-46. PubMed ID: 8794754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding and domain-domain interactions of the chaperone PapD measured by 19F NMR.
    Bann JG; Frieden C
    Biochemistry; 2004 Nov; 43(43):13775-86. PubMed ID: 15504040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate-limiting steps for the folding of an antibody scFv fragment.
    Jäger M; Plückthun A
    FEBS Lett; 1997 Nov; 418(1-2):106-10. PubMed ID: 9414105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding of the yeast prion protein Ure2: kinetic evidence for folding and unfolding intermediates.
    Galani D; Fersht AR; Perrett S
    J Mol Biol; 2002 Jan; 315(2):213-27. PubMed ID: 11779240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D; Honegger A; Plückthun A
    J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization.
    Thies MJ; Mayer J; Augustine JG; Frederick CA; Lilie H; Buchner J
    J Mol Biol; 1999 Oct; 293(1):67-79. PubMed ID: 10512716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folding and oxidation of the antibody domain C(H)3.
    Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
    J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal unfolding of an intermediate is associated with non-Arrhenius kinetics in the folding of hen lysozyme.
    Matagne A; Jamin M; Chung EW; Robinson CV; Radford SE; Dobson CM
    J Mol Biol; 2000 Mar; 297(1):193-210. PubMed ID: 10704316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond.
    Kameda A; Hoshino M; Higurashi T; Takahashi S; Naiki H; Goto Y
    J Mol Biol; 2005 Apr; 348(2):383-97. PubMed ID: 15811375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
    Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
    Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupled kinetic traps in cytochrome c folding: His-heme misligation and proline isomerization.
    Pierce MM; Nall BT
    J Mol Biol; 2000 May; 298(5):955-69. PubMed ID: 10801361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding of horse cytochrome c in the reduced state.
    Bhuyan AK; Udgaonkar JB
    J Mol Biol; 2001 Oct; 312(5):1135-60. PubMed ID: 11580255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.